Search academic texts

Information × Registration Number 0208U002478, 0105U000980 , R & D reports Title Development of phensuccinal soft pharmaceutical dosage form for treatment of foot ulcerous damage in diabetes (preclinical study) popup.stage_title Head Poltorack Victoria Vitaliyivna, Доктор медичних наук Registration Date 31-01-2008 Organization State Institution "V.J. Danilevsky Institute of Endocrine Pathology Problems of Academy of Medical Sciences of Ukraine" popup.description2 Object of research: phensuccinal soft pharmaceutical dosage forms and their reparative activity as for healing of surface skin damages, which arise at experimental diabetes. The aim of the study: is the experimental ground of phensuccinal soft pharmaceutical dosage form as the remedy for topical use. Methods: organic synthesis, physico-chemical, analytical, рharmtechnological, pharmacological, biochemical. The technology of achieving soft pharmaceutical dosage form of phensuccinal based on oil / water emulsion with the use of emulsifiers № 1 or its combination with Carbopol is developed; the method of quality control is proposed. The soft pharmaceutical dosage form of phensuccinal to oppress inflammation at its exudative and alterative stages, when type 1 diabetes of various degrees of compensation is absent or present, is obtained. The branches of the use are health care, clinical and experimental diabetologia, pharmaceutical industry Product Description popup.authors popup.nrat_date 2020-04-02 Close